MedTrace Logo

SBRT Treatment for Lung Metastasis From Soft Tissue Sarcoma

NCT02561559 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2022-05-04

No results posted yet for this study

Summary

In this study the investigators treat PM oligometastatic patients with SBRT. Our objective is to evaluate rate of local control of treated lesions in patients treated with Intensity Modulated Radiation Therapy (IMRT) using Volumetric Modulated Arc Therapy (VMAT) for lung metastases from STS.

Conditions

  • Metastasis From Malignant Tumor of Soft Tissues

Interventions

RADIATION

Lung metastasis from soft-tissue sarcoma

Tretament based on Intensity Modulated Radiation Therapy (IMRT) using Volumetric Modulated Arc Therapy (VMAT)

Sponsors & Collaborators

  • Istituto Clinico Humanitas

    lead OTHER

Principal Investigators

  • Marta Scorsetti, MD · Istituto Clinico Humanitas

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-10
Primary Completion
2023-01-31
Completion
2023-01-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02561559 on ClinicalTrials.gov